Catalyst Capital Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9K Buy
2025
Q3
Sell
2025
Q2
$148K Buy
2016
Q1
Sell
2015
Q4
$94K Sell
2015
Q3
$884K Sell
2015
Q2
$15.6M Sell
2015
Q1
$20.9M Buy